Scientific Research on Human Subjects History and Ethical Principles Modified from: Jeffrey M. Cohen, Ph.D. Director, Division of Education Office for Human Research Protections

Pre WWII Edward Jenner (1789) Smallpox Vaccine Louis Pasteur (1885) Rabies Vaccine Walter Reed (1900) Yellow Fever

Nuremberg During the Nuremberg War Crimes Trials, 23 German doctors were charged with crimes against humanity for “performing medical experiments upon concentration camp inmates and other living human subjects, without their consent, in the course of which experiments the defendants committed the murders, brutalities, cruelties, tortures, atrocities, and other inhuman acts.”

The Nuremberg Code (1947) As part of the verdict, the Court enumerated some rules for "Permissible Medical Experiments", now known as the “Nuremberg Code”. These rules include: voluntary consent benefits outweigh risks ability of the subject to terminate participation

Tuskegee Syphilis Study American medical research project conducted by the U.S. Public Health Service from 1932 to 1972, examined the natural course of untreated syphilis in black American men. The subjects, all impoverished sharecroppers from Macon county, Alabama, were unknowing participants in the study; they were not told that they had syphilis, nor were they offered effective treatment. https://www.youtube.com/watch?v=yi5RNp2XS3k

Post WWII Willowbrook (1950s) Mentally retarded children housed at the Willowbrook State School in Staten Island, New York, were intentionally given hepatitis in an attempt to track the development of the viral infection. The study began in 1956 and lasted for 14 years.

Post WWII Jewish Chronic Disease Hospital (1960s) Live cancer cells were injected into 22 senile patients Without their knowledge or consent

Post WWII Milgram (1963) "Behavioral study of obedience“ ttps://www.youtube.com/watch?v=xOYLCy5PVgM Lessons learned: participants need to given informed consent; psychological harm also needs to be considered

Declaration of Helsinki Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964 and as revised by the World Medical Assembly in Tokyo, Japan in 1975, in Venice, Italy in 1983, and in Hong Kong in 1989 and the 48th General Assembly, Somerset West, Republic of South Africa, October 1996 “Concern for the interests of the subject must always prevail over the interests of science and society.”

Declaration of Helsinki informed consent a central requirement for ethical research while allowing for surrogate consent when the research participant is incompetent, physically or mentally incapable of giving consent, or a minor research should be conducted only when the research is necessary to promote the health of the population represented and when this research cannot be performed on legally competent persons. when the participant is legally incompetent but able to give assent to decisions about participation in research, assent must be obtained in addition to the consent of the legally authorized representative. first significant effort of the medical community to regulate itself

National Research Act 1973 Kennedy Hearings “Quality of Health Care - Human Experimentation” 1974 National Research Act Established the “National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research” Required IRBs at institutions receiving HEW support for human subjects research IRB: Institutional Review Boards

The Belmont Report Ethical Principles and Guidelines for the Protection of Human Subjects of Research The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research April 18, 1979 The cornerstone of ethical principles upon which Federal regulations for the protection of human research participants are based. 

The Belmont Report Basic Ethical Principles: Respect for Persons Individual autonomy Protection of individuals with reduced autonomy Beneficence Maximize benefits and minimize harms Ensure the rights and well-being of the patient take precedence over the needs of science Justice Equitable distribution of research costs and benefits

Federal Regulations and Policy 45 CFR 46 - Basic DHHS Policy for Protection of Human Research Subjects Originally adopted May, 1974, Revised January 13, 1981, Revised June 18, 1991 Additional protections for vulnerable populations in Subparts B-D Federal Policy for the Protection of Human Subjects - “The Common Rule” June 18, 1991 Departments of Agriculture, Energy, Commerce, HUD, Justice, Defense, Education, Veterans Affairs, Transportation, and HHS. NSF, NASA, EPA, AID, Social Security Administration, CIA, and the Consumer Product Safety Commission.

Basic Protections The regulations contain three basic protections for human subjects: Institutional Assurances IRB Review Informed Consent

Institutional Responsibilities Institutions bear full responsibility for all research involving human subjects covered under their Assurance All requirements of 45 CFR 46 must be met for all federally-sponsored research OHRP strongly encourages institutions to embrace the HHS regulations regardless of sponsorship, and to commit to this standard in their Assurance.

IRB Decision Matrix BENEFICENCE JUSTICE RESPECT FOR PERSONS Risk/Benefit Analysis Experimental Design Qualifications of PI Subject selection Inclusion/exclusion Recruitment Protection of subjects (especially vulnerable populations) Informed consent Surrogate consent Assent J. Cooper, Albany Medical Center

The Consent Process Informed consent is not a single event or just a form to be signed -- rather, it is an educational process that takes place between the investigator and the prospective subject. The basic elements of the consent process include: full disclosure of the nature of the research and the subject's participation, adequate comprehension on the part of the potential subjects, and the subject's voluntary choice to participate. Adequate Informed Consent. Only the subjects can evaluate the degree of risk in a given situation. The IRB must ensure that subjects are given sufficient information regarding the study to determine for themselves what the risks are and whether they want to assume those risks. Must be understandable to subjects: Risks described in terms that the subjects can understand. Comparisons to everyday risks. Avoid Bias and Creation of Negative Mindsets: Consent process should not increase the likelihood of harm.

Tampa Tribune 3/11/00 TAMPA - A lawsuit accusing USF doctors of experimenting on pregnant women without their consent is settled for $3.8 million…. The experiment wasn't considered risky and no adverse effects were documented, plaintiffs in the suit agree. However, the failure to inform … as many as 3,000 ... pregnant women of various experiments conducted between 1986 and 1990 has cost Tampa General Hospital, USF and the state $3.8 million.

Overarching Concerns Does the institution support and respect the IRB and its mission? Is there a “culture of compliance”? Are IRB members and investigators knowledgeable about regulatory requirements? Is there adequate documentation of IRB findings and actions?